KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 73 filers reported holding KINNATE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $588,819 | +24495.6% | 420,585 | +53138.6% | 0.00% | – |
| Q2 2023 | $2,394 | -24.1% | 790 | +56.4% | 0.00% | – |
| Q1 2023 | $3,156 | -30.7% | 505 | -32.4% | 0.00% | – |
| Q4 2022 | $4,557 | -58.6% | 747 | -21.6% | 0.00% | – |
| Q3 2022 | $11,000 | -68.6% | 953 | -65.4% | 0.00% | – |
| Q2 2022 | $35,000 | -36.4% | 2,757 | -43.3% | 0.00% | – |
| Q1 2022 | $55,000 | -64.7% | 4,863 | -44.7% | 0.00% | – |
| Q4 2021 | $156,000 | +79.3% | 8,792 | +131.5% | 0.00% | – |
| Q3 2021 | $87,000 | +163.6% | 3,798 | +170.7% | 0.00% | – |
| Q2 2021 | $33,000 | +6.5% | 1,403 | +41.0% | 0.00% | – |
| Q1 2021 | $31,000 | -94.9% | 995 | -93.5% | 0.00% | – |
| Q4 2020 | $607,000 | – | 15,263 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $225,156,000 | 30.44% |
| Vida Ventures Advisors, LLC | 2,747,433 | $63,960,000 | 16.04% |
| Foresite Capital Management V, LLC | 875,001 | $20,370,000 | 8.01% |
| VR Adviser, LLC | 1,473,014 | $34,292,000 | 4.16% |
| Logos Global Management LP | 1,329,602 | $30,953,000 | 2.60% |
| RA Capital Management | 3,593,052 | $83,646,000 | 1.34% |
| Orbimed Advisors | 3,847,929 | $89,580,000 | 0.91% |
| Boxer Capital, LLC | 1,065,939 | $24,815,000 | 0.88% |
| HARVARD MANAGEMENT CO INC | 498,001 | $11,593,000 | 0.67% |
| HighVista Strategies LLC | 33,391 | $777,000 | 0.55% |